Bioactive Compounds
-
BA2282 YH-53Summary: YH-53 is a potent inhibitor. -
N1633 Eleutheroside E - BA2281 BamlanivimabSummary: Bamlanivimab (Anti-HumanSARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020.
-
N1606 Prim-O-glucosylcimifugin - BA2280 GRL-0496Summary: GRL-0496 is a potent chloropyridine ester-derived inhibitor.
- BA2279 X77Summary: X77 is a potent non-covalent bond inhibitor of the SARS-CoV-2 protease.
-
N1492 vitexin-2″-o-rhamnoside - BA2278 rel-ZotatifinSummary: re-Zotatifin is a racemic isomer of Zotatifin and is less active than Zotatifin as an eIF4A inhibitor.
-
N1447 10-Gingerol - BA2277 XR8-89Summary: XR8-89 is a potent papain-like inhibitor.